Skip to content

Effects of Pelvic Belt and Kinesio Tape on Pain and Functional Mobility in Pregnancy-Related Pelvic Girdle Pain

Gebeliğe Bağlı Pelvik Kuşak Ağrısında Pelvik Kemer ve Kinezyo Bant Uygulamalarının Ağrı ve Fonksiyonel Mobilite Üzerine Etkileri

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04266184
Enrollment
47
Registered
2020-02-12
Start date
2020-03-13
Completion date
2022-02-28
Last updated
2021-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Girdle Pain

Keywords

kinesio tape, pelvic belt, functional mobility, pain, kinesiophobia, neuroscience education, ergonomic education, activity limitation

Brief summary

This study investigates the effects of pelvic belt (PB) and kinesio taping (KT) applications on pain and functional mobility in pregnancy-related pelvic girdle pain (PGP), in comparison with the control group that received only pain neuroscience education and ergonomic training.

Detailed description

Although there is strong evidence in the literature that pelvic support belts reduce pain in pregnancy-related pelvic girdle pain, no study investigating its effect on functional mobility with performance-based measurement methods or investigating its effectiveness on kinesiophobia has been found. Studies investigating the efficacy of KT in pregnant women with PGP are few and many are methodologically weak studies, most of which do not contain randomization and control groups. Also, no study has been found in the literature, which compares the effectiveness of PB and KT in pregnant women with PGP. Therefore, the primary aim of this study is to examine the effects of PB and KT on pain and functional mobility in pregnant women with PGP in comparison with the control group, which is only given pain neuroscience education and ergonomic training. The secondary aims are to investigate the effects of these applications on kinesiophobia, activity limitation and sleep quality; and to compare the groups in regard to patient compliance and treatment satisfaction levels of the groups.

Interventions

OTHERKinesio tape (KT)

For abdominal taping, four I-shaped tapes will be used. Two of them will start from the superior symphisis pubis, follow the rectus abdominis muscle, and finish at the xiphoid process. Other two I-shaped tapes will start from the mid-symphisis pubis, follow the external oblique abdominals, and finish at the spina iliaca anterior superiors. Symphisis pubis taping will be applied with two I-shaped tapes, by forming a X shape. For lumbopelvic taping, three I-shaped KTs will be used. Two tapes will be applied bilaterally and longitudinally on the lumbar erector spinal muscles. The third tape will start from one sacroiliac joint and end at the other, vertically to the previous two tapes, forming a H-shape. All tapings will be applied with 15-25% tension (tape-off tension). KTs will stay three days. They will be removed from the site, and the skin will be checked and cleaned. Then, they will be reapplied for the next three days.

OTHERPelvic belt (PB)

The women in this group will use the belts, after adjusting them at a comfortable tension, after getting up the bed in the mornings, during daily activities and walking. Evaluation will be made three days after the first application and they will be asked to continue using it for the second three-day period.

OTHEREducational program

This program will include pain neuroscience education and ergonomic education, and will approximately last one hour.

Sponsors

Bezmialem Vakif University
CollaboratorOTHER
Muğla Sıtkı Koçman University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* being able to read and write in Turkish * being in 2nd or 3rd trimester of pregnancy * having PGP for more than one week * signing the informed consent form for the study

Exclusion criteria

* visual, auditory or cognitive problems which may prevent participation to the study * health problems other than pregnancy-related PGP (orthopedic, neurologic, cardiorespiratory, etc.) or trauma history, which may affect standing from sitting, walking or stair climbing activities * any gynecological or urological problems which may mimic pregnancy related PGP * any diagnosed pregnancy complications other than PGP (preeclampsy, hypertension, diabetes,placental/fetal anomaly, preterm labor, etc.) * high risk pregnancy (multiple gestation, etc.) * history of spinal injury, ankylosing spondilitis, rheumatoid arthritis, intervertebral disc pathology) * A positive straight leg raise test result, as well as sensory or motor deficits indicating intervertebral disc pathology * history of prepregnancy low back or pelvic girdle pain * using any analgesic or myorelaxant medication * contraindications to KT or PB (impaired skin integrity or lesion in the lumbopelvic and abdominal regions, history of allergic reaction, etc.) * previous KT (abdominal or lumbosacral) or PB experience

Design outcomes

Primary

MeasureTime frameDescription
change in impairment during active straight leg raise testbaseline, approximately one-hour after the first intervention, three days after the first intervention, one week after the first intervention, and one week after cessation of interventionThe women will be asked to score their impairment during active straight leg raise test. 0 (not difficult at all)-5 (unable to do) scoring system will be used. Scores for right and left legs will be summed and recorded.
change in general pain intensity during activitybaseline, approximately one-hour after the first intervention, three days after the first intervention, one week after the first intervention, and one week after cessation of interventionThe women will be asked to mark their pain intensity during activities in general. 0 (no pain)-10 cm (unbearable pain) visual analogue scale will be used.
change in pain intensity during five times sit to stand testbaseline, approximately one-hour after the first intervention, three days after the first intervention, one week after the first intervention, and one week after cessation of interventionThe women will be asked to mark their pain intensity during five times sit to stand test. 0 (no pain)-10 cm (unbearable pain) visual analogue scale will be used.
change in pain intensity during five-stairs climbing testbaseline, approximately one-hour after the first intervention, three days after the first intervention, one week after the first intervention, and one week after cessation of interventionThe women will be asked to mark their pain intensity during five-stairs climbing test. 0 (no pain)-10 cm (unbearable pain) visual analogue scale will be used.
change in pain intensity during timed up and go testbaseline, approximately one-hour after the first intervention, three days after the first intervention, one week after the first intervention, and one week after cessation of interventionThe women will be asked to mark their pain intensity during timed up and go test. 0 (no pain)-10 cm (unbearable pain) visual analogue scale will be used.

Secondary

MeasureTime frameDescription
change in kinesiophobiabaseline, three days after the first intervention, one week after the first intervention, and one week after cessation of interventionTurkish version of Tampa Kinesiophobia Scale will be used. The score ranges between 17 and 68, and higher score indicates higher kinesiophobia.
change in activity limitationbaseline, three days after the first intervention, one week after the first intervention, and one week after cessation of interventionTurkish version of Pelvic Girdle Questionnaire will be used. Total score varies between 0 and 75, and higher score indicates higher activity limitation.
change in sleep qualitybaseline, three days after the first intervention, one week after the first intervention, and one week after cessation of interventionQuality of sleep will be assessed on a 0 (very bad)-10 (very good) cm VAS.
patient compliancebaseline, three days after the first intervention, one week after the first intervention, and one week after cessation of interventionFor PB and KT groups, comfort and easiness of using PB and KT will be assessed by 0 (not at all)-10 (extremely comfortable/easy) cm VASs. All groups will be questioned about the comprehensibility of the educational program on 0 (not at all)-10 (completely comprehensible) cm VASs. Also, degree of following the suggestions given in the educational program will be evaluated by 0 (not at all)-10 (completely) cm VASs.
treatment satisfactionbaseline, three days after the first intervention, one week after the first intervention, and one week after cessation of interventionTreatment satisfaction will be assessed by 0 (not at all)-10 (extremely satisfactory) cm VASs.

Countries

Turkey (Türkiye)

Contacts

Primary Contactİlkim Çıtak Karakaya
ilkim74@yahoo.com05323611451
Backup ContactDilan Aydemir
dilanaydemir_@hotmail.com+905372199221

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026